Insulin resistance and nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH)
-д хадгалсан:
| Үндсэн зохиолч: | |
|---|---|
| Байгууллагын зохиогч: | |
| Формат: | Цахим Цахим ном |
| Хэл сонгох: | англи |
| Хэвлэсэн: |
New York :
Nova Biomedical Books,
c2010.
|
| Цуврал: | Metabolic diseases--laboratory and clinical research series.
Novinka (Series) |
| Нөхцлүүд: | |
| Онлайн хандалт: | An electronic book accessible through the World Wide Web; click to view |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|
MARC
| LEADER | 00000nam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | 0000167489 | ||
| 005 | 20171002063411.0 | ||
| 006 | m u | ||
| 007 | cr cn||||||||| | ||
| 008 | 100616s2010 nyua sb 001 0 eng d | ||
| 010 | |z 2010025523 | ||
| 020 | |z 9781616689278 (softcover) | ||
| 020 | |z 1616689277 (softcover) | ||
| 020 | |z 9781617284809 (e-book) | ||
| 035 | |a (CaPaEBR)ebr10681073 | ||
| 035 | |a (OCoLC)711000219 | ||
| 040 | |a CaPaEBR |c CaPaEBR | ||
| 050 | 1 | 4 | |a RC848.F3 |b Y66 2010eb |
| 082 | 0 | 4 | |a 616.3/62 |2 22 |
| 100 | 1 | |a Yoneda, Masato. | |
| 245 | 1 | 0 | |a Insulin resistance and nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) |h [electronic resource] / |c Masato Yoneda ... [et al.]. |
| 260 | |a New York : |b Nova Biomedical Books, |c c2010. | ||
| 300 | |a viii, 54 p. : |b col. ill. | ||
| 490 | 1 | |a Metabolic diseases--laboratory and clinical research | |
| 490 | 1 | |a Novinka | |
| 504 | |a Includes bibliographical references and index. | ||
| 505 | 0 | |a NAFLD and insulin resistance (IR) -- Pathophysiology of NASH : insulin resistance, free fatty acids, and cytokines -- Adiponectin and NASH -- TNF-[alpha] and NAFLD/NASH -- Leptin and NAFLD/NASH -- Peroxisome proliferators-activated receptors (PPARs) and NAFLD/NASH -- Iron overload and NAFLD/NASH -- Mitochondrial abnormalities and NAFLD/NASH -- Genetic influences in NAFLD/NASH -- Therapeutic strategy for NASH patients -- Natural history of NAFLD -- Conclusions. | |
| 533 | |a Electronic reproduction. |b Palo Alto, Calif. : |c ebrary, |d 2013. |n Available via World Wide Web. |n Access may be limited to ebrary affiliated libraries. | ||
| 650 | 0 | |a Fatty liver. | |
| 650 | 0 | |a Insulin resistance. | |
| 655 | 7 | |a Electronic books. |2 local | |
| 710 | 2 | |a ebrary, Inc. | |
| 830 | 0 | |a Metabolic diseases--laboratory and clinical research series. | |
| 830 | 0 | |a Novinka (Series) | |
| 856 | 4 | 0 | |u http://site.ebrary.com/lib/daystar/Doc?id=10681073 |z An electronic book accessible through the World Wide Web; click to view |
| 908 | |a 170314 | ||
| 942 | 0 | 0 | |c EB |
| 999 | |c 156633 |d 156633 | ||